Neurocrine Biosciences' Chief Commercial Officer Buys, Sells Shares on November 28, 2025.

Neurocrine Biosciences Inc. (NBIX) recently announced that Chief Commercial Officer Eric Benevich has engaged in a transaction involving the company's shares. Specifically, Benevich sold 5970 shares at a price of $151.74 per share on November 28, 2025. Subsequently, he purchased 5970 shares at a price of $35.99 per share on the same date. This transaction highlights Benevich's confidence in the company's prospects and underscores his commitment to driving long-term value for Neurocrine Biosciences.